10x Genomics, Inc.
MX ˙ BMV ˙ US88025U1097
SecurityMX:TXG / 10x Genomics, Inc.
InstitutionAmeriprise Financial Inc
Latest Disclosed Ownership332,524 shares
Latest Disclosed Value $ 7,059,485
Ameriprise Financial Inc reports 13.22% decrease in ownership of TXG / 10x Genomics, Inc.

On May 15, 2026 - Ameriprise Financial Inc filed a 13F-HR form disclosing ownership of 332,524 shares of 10x Genomics, Inc. (MX:TXG) valued at $7,059,485 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 383,169 shares of 10x Genomics, Inc.. This represents a change in shares of -13.22% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F 10X GENOMICS INC- COM 88025U109 332,524 -50,645 -13.22 7,059 12.96 0.0003
2026-02-17 2025-12-31 13F 10X GENOMICS INC- COM 88025U109 383,169 41,028 11.99 6,249 56.26 0.0014
2025-11-14 2025-09-30 13F 10X GENOMICS INC- COM 88025U109 342,141 -101,608 -22.90 4,000 -22.17 0.0009
2025-08-14 2025-06-30 13F 10X GENOMICS INC- COM 88025U109 443,749 313,160 239.81 5,139 350.70 0.0013
2025-05-14 2025-03-31 13F 10X GENOMICS INC- COM 88025U109 130,589 130,589 1,140 0.0003
2025-02-14 2024-12-31 13F 10X GENOMICS INC- COM 88025U109 0 -77,371 -100.00 0 -100.00
2024-11-14 2024-09-30 13F 10X GENOMICS INC- COM 88025U109 77,371 16,810 27.76 1,747 48.43 0.0004
2024-08-14 2024-06-30 13F 10X GENOMICS INC- COM 88025U109 60,561 -405,793 -87.01 1,178 -93.28 0.0003
2024-05-15 2024-03-31 13F 10X GENOMICS INC- COM 88025U109 466,354 -48,987 -9.51 17,502 -39.31 0.0048
2024-02-14 2023-12-31 13F 10X GENOMICS INC- COM 88025U109 515,341 500,802 3,444.54 28,838 4,714.36 0.0086
2023-11-14 2023-09-30 13F 10X GENOMICS INC- COM 88025U109 14,539 -15,845 -52.15 600 -64.68 0.0002
2023-08-14 2023-06-30 13F 10X GENOMICS INC- COM 88025U109 30,384 -22,736 -42.80 1,697 -42.76 0.0005
2023-05-22 2023-03-31 13F/A-1 10X GENOMICS INC- COM 88025U109 53,120 -5,704 -9.70 2,964 38.26 0.0010
2023-05-15 2023-03-31 13F TENABLE HOLDINGS COM 88025U109 53,120 -5,704 2,964 0.0002
2023-02-14 2022-12-31 13F 10X GENOMICS INC- COM 88025U109 58,824 6,057 11.48 2,143 42.77 0.0007
2022-11-14 2022-09-30 13F 10X GENOMICS INC- COM 88025U109 52,767 -4,747 -8.25 1,501 -42.36 0.0006
2022-08-15 2022-06-30 13F 10X GENOMICS INC- COM 88025U109 57,514 -1,578,382 -96.48 2,604 -97.91 0.0009
2022-05-16 2022-03-31 13F 10X GENOMICS INC- COM 88025U109 1,635,896 40,627 2.55 124,432 -47.63 0.0367
2022-02-14 2021-12-31 13F 10X GENOMICS INC- COM 88025U109 1,595,269 520,671 48.45 237,606 51.89 0.0657
2021-11-15 2021-09-30 13F 10X GENOMICS INC- COM 88025U109 1,074,598 -255,124 -19.19 156,435 -39.92 0.0500
2021-08-16 2021-06-30 13F 10X GENOMICS INC- COM 88025U109 1,329,722 -79,485 -5.64 260,385 2.08 0.0805
2021-05-17 2021-03-31 13F 10X GENOMICS INC- COM 88025U109 1,409,207 37,573 2.74 255,070 31.33 0.0848
2021-02-12 2020-12-31 13F 10X GENOMICS INC- COM 88025U109 1,371,634 606,538 79.28 194,220 103.60 0.0689
2020-11-16 2020-09-30 13F 10X GENOMICS INC- COM 88025U109 765,096 224,219 41.45 95,393 97.48 0.0388
2020-08-14 2020-06-30 13F 10X GENOMICS INC- COM 88025U109 540,877 347,974 180.39 48,304 301.80 0.0207
2020-05-15 2020-03-31 13F 10X GENOMICS INC- COM 88025U109 192,903 176,093 1,047.55 12,022 838.49 0.0063
2020-02-14 2019-12-31 13F 10X GENOMICS INC- COM 88025U109 16,810 6,086 56.75 1,281 137.22 0.0005
2019-11-14 2019-09-30 13F 10X GENOMICS INC- COM 88025U109 10,724 10,724 540 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.